# TAAR5

## Overview
The TAAR5 gene encodes the trace amine-associated receptor 5, a member of the G protein-coupled receptor (GPCR) family, which is characterized by its seven transmembrane domains. This receptor is primarily involved in olfactory signaling and the detection of trace amines, which are biogenic amines present in low concentrations in the brain (Cichero2016A; Vaganova2021Pattern). TAAR5 is expressed in various brain regions, including those associated with emotional and cognitive functions, such as the limbic system, suggesting its potential role in neuropsychiatric disorders (Vaganova2021Pattern). The receptor's involvement in modulating neurotransmitter systems, particularly serotonin, underscores its significance in emotional and olfactory processing (Espinoza2020Trace). Additionally, TAAR5 has been implicated in several clinical conditions, including major depressive disorder, Down syndrome, and certain cancer subtypes, highlighting its diverse physiological and pathological roles (Vaganova2021Pattern; Vaganova2023The).

## Structure
The trace amine-associated receptor 5 (TAAR5) is a G protein-coupled receptor (GPCR) characterized by its seven transmembrane alpha-helices, a common feature of GPCRs. The primary structure of TAAR5 is encoded by the TAAR5 gene, and the receptor is involved in olfactory signaling. The secondary structure includes transmembrane helices that form the core of the receptor, facilitating its function in signal transduction (Cichero2016A).

In terms of tertiary structure, TAAR5 shares structural similarities with other GPCRs, such as the human β2-adrenoreceptor, which was used as a template for homology modeling. This modeling revealed key residues involved in ligand binding, such as D114 in TM3, which forms a salt-bridge with ligands, and aromatic residues in TM6 and TM7 that interact with the phenolic ring of ligands (Cichero2016A).

Post-translational modifications, such as phosphorylation and glycosylation, are likely to affect the receptor's function and localization, although specific modifications for TAAR5 are not detailed in the provided context. The receptor's structure allows for species-specific ligand interactions, as evidenced by differences in binding modes between human and mouse TAAR5 (Cichero2016A).

## Function
TAAR5 (trace amine-associated receptor 5) is a G protein-coupled receptor (GPCR) that plays a significant role in the detection of trace amines, which are biogenic amines present in low concentrations in the brain. It is primarily involved in olfactory sensing, particularly in recognizing volatile amines associated with socially relevant odors (Vaganova2021Pattern). TAAR5 is expressed in various brain regions, including the limbic system, which is involved in emotional behaviors and monoamine transmission, suggesting its potential role in neuropsychiatric diseases (Vaganova2021Pattern).

In healthy human cells, TAAR5 is expressed in the nucleus accumbens, thalamus, hypothalamus, striatum, cerebellum, substantia nigra, and white matter, with varying levels of expression (Vaganova2021Pattern). The receptor is implicated in modulating emotional behaviors and serotonin transmission, as evidenced by studies in TAAR5 knockout mice, which show altered serotonin levels and emotional responses (Espinoza2020Trace). TAAR5's involvement in these processes indicates its role in the regulation of neurotransmitter systems and its potential impact on emotional and olfactory processing, which may have implications for understanding the pathogenesis of neuropsychiatric disorders (Vaganova2021Pattern).

## Clinical Significance
Alterations in the expression of the TAAR5 gene have been linked to various neuropsychiatric disorders. Studies have shown that TAAR5 expression is significantly downregulated in the prefrontal cortex of individuals with major depressive disorder, suggesting a potential role in the pathogenesis of depression (Vaganova2021Pattern). In contrast, no significant changes in TAAR5 expression have been observed in bipolar disorder or schizophrenia (Vaganova2021Pattern). TAAR5 knockout mice exhibit anxiolytic and antidepressant-like behaviors, indicating that TAAR5 may influence emotional responses through the serotonin system (Espinoza2020Trace).

TAAR5 expression is also implicated in Down syndrome, where it is downregulated, and in HIV-associated encephalitis, where it is upregulated in white matter, possibly due to B-cell infiltration (Vaganova2021Pattern). In the context of diabetic nephropathy, altered TAAR5 expression in the kidneys of diabetic rats suggests a potential role in renal damage (RuizHernández2020Diabetic).

In breast cancer, TAAR5 expression varies across tumor subtypes, with higher levels in basal-like and HER2-positive tumors, indicating potential implications for therapeutic targeting (Vaganova2023The). These findings highlight the diverse clinical significance of TAAR5 in various diseases and conditions.

## Interactions
TAAR5, a trace amine-associated receptor, is involved in various signaling interactions primarily through its role as a G protein-coupled receptor (GPCR). It interacts with G proteins to transduce signals within cells, influencing pathways related to neurotransmission and olfactory processes. TAAR5 is known to modulate the serotonin system, as evidenced by its co-expression with TAAR1 in the amygdala. This interaction affects serotonin levels and enhances the function of 5-HT1A receptors, which are crucial for mood regulation and cognitive functions (Bon2022Discovery).

TAAR5 also participates in intracellular signaling pathways, such as those involving ERK and CREB phosphorylation. These pathways are activated by the endogenous ligand trimethylamine (TMA), which increases cAMP levels, leading to the phosphorylation of ERK and CREB. This signaling can be inhibited by specific TAAR5 antagonists, which block the phosphorylation of these proteins, demonstrating the receptor's role in modulating intracellular signaling cascades (Bon2022Discovery).

Additionally, TAAR5's interaction with 3-iodothyronamine (3-T1AM) as an inverse agonist at human TAAR5 (hTAAR5) highlights its involvement in reducing basal IP3 signaling and affecting MAP kinase pathway activation, further illustrating its role in complex signaling networks (Dinter2015Inverse).


## References


[1. (Cichero2016A) Elena Cichero, Stefano Espinoza, Michele Tonelli, Silvia Franchini, Andrey S. Gerasimov, Claudia Sorbi, Raul R. Gainetdinov, Livio Brasili, and Paola Fossa. A homology modelling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (taar5) antagonists. MedChemComm, 7(2):353–364, 2016. URL: http://dx.doi.org/10.1039/c5md00490j, doi:10.1039/c5md00490j. This article has 30 citations.](https://doi.org/10.1039/c5md00490j)

[2. (RuizHernández2020Diabetic) A. Ruiz-Hernández, S. Cabrera-Becerra, G. Vera-Juárez, E. Hong, H. Fengyang, J. Arauz, and S. Villafaña. Diabetic nephropathy produces alterations in the tissue expression profile of the orphan receptors gpr149, gpr153, gpr176, taar3, taar5 and taar9 in wistar rats. Nucleosides, Nucleotides &amp; Nucleic Acids, 39(8):1150–1161, July 2020. URL: http://dx.doi.org/10.1080/15257770.2020.1780437, doi:10.1080/15257770.2020.1780437. This article has 6 citations.](https://doi.org/10.1080/15257770.2020.1780437)

[3. (Dinter2015Inverse) Juliane Dinter, Jessica Mühlhaus, Carolin Leonie Wienchol, Chun-Xia Yi, Daniela Nürnberg, Silke Morin, Annette Grüters, Josef Köhrle, Torsten Schöneberg, Matthias Tschöp, Heiko Krude, Gunnar Kleinau, and Heike Biebermann. Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5. PLOS ONE, 10(2):e0117774, February 2015. URL: http://dx.doi.org/10.1371/journal.pone.0117774, doi:10.1371/journal.pone.0117774. This article has 60 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0117774)

[4. (Espinoza2020Trace) Stefano Espinoza, Ilya Sukhanov, Evgeniya V. Efimova, Alena Kozlova, Kristina A. Antonova, Placido Illiano, Damiana Leo, Natalia Merkulyeva, Daria Kalinina, Pavel Musienko, Anna Rocchi, Liudmila Mus, Tatiana D. Sotnikova, and Raul R. Gainetdinov. Trace amine-associated receptor 5 provides olfactory input into limbic brain areas and modulates emotional behaviors and serotonin transmission. Frontiers in Molecular Neuroscience, March 2020. URL: http://dx.doi.org/10.3389/fnmol.2020.00018, doi:10.3389/fnmol.2020.00018. This article has 49 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2020.00018)

[5. (Vaganova2021Pattern) Anastasia N. Vaganova, Ramilya Z. Murtazina, Taisiia S. Shemyakova, Andrey D. Prjibelski, Nataliia V. Katolikova, and Raul R. Gainetdinov. Pattern of taar5 expression in the human brain based on transcriptome datasets analysis. International Journal of Molecular Sciences, 22(16):8802, August 2021. URL: http://dx.doi.org/10.3390/ijms22168802, doi:10.3390/ijms22168802. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22168802)

[6. (Bon2022Discovery) Carlotta Bon, Ting-Rong Chern, Elena Cichero, Terrence E. O’Brien, Stefano Gustincich, Raul R. Gainetdinov, and Stefano Espinoza. Discovery of novel trace amine-associated receptor 5 (taar5) antagonists using a deep convolutional neural network. International Journal of Molecular Sciences, 23(6):3127, March 2022. URL: http://dx.doi.org/10.3390/ijms23063127, doi:10.3390/ijms23063127. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms23063127)

[7. (Vaganova2023The) Anastasia N. Vaganova, Daria D. Maslennikova, Valeria V. Konstantinova, Evgeny V. Kanov, and Raul R. Gainetdinov. The expression of trace amine-associated receptors (taars) in breast cancer is coincident with the expression of neuroactive ligand–receptor systems and depends on tumor intrinsic subtype. Biomolecules, 13(9):1361, September 2023. URL: http://dx.doi.org/10.3390/biom13091361, doi:10.3390/biom13091361. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom13091361)